Viz Subdural Hematoma (SDH), a new artificial intelligence (AI)-powered algorithm for diagnosing subdural hemorrhages, has garnered 510(k) clearance from the Food and Drug Administration (FDA), according to Viz.ai, the manufacturer of the module. Noting a rising incidence of subdural hematomas, Viz.ai said the SDH algorithm demonstrated sensitivity and specificity rates of 94 and 92 percent respectively in a multicenter trial of over 500 patients.1,2 "The algorithm is very sensitive and specific, significantly increasing the number of subdural hemorrhages detected and ensuring patients receive the necessary follow-up from this potentially life-threatening disease," maintained Jayme Strauss, the chief clinical officer at Viz.ai. The company emphasizes that Viz SDH is currently the only AI-powered platform specifically geared to identifying and differentiating between acute and chronic subdural hemorrhages. Jason Davies, M.D., Ph.D., said this is a key benefit given the different treatment pathways for these conditions.

Viz.ai announced it has received U.S. Food and Drug Administration (FDA) 501(k) clearance for Viz SDH, which uses artificial intelligence (AI) to detect subdural hemorrhage (SDH). By detecting SDH automatically, Viz SDH allows physicians to triage patients effectively and deliver care, according to the company. Viz.ai notes that subdural hemorrhage is projected to become the most common neurosurgical diagnosis by 2031, and global clinical trials are investigating new treatments to address this disease. Viz SDH has the capability to identify acute and chronic subdural bleeds and notify the care team in the event of a necessary immediate intervention, according to Viz.ai.

Viz.ai announced today that it partnered with Hyperfine (Nasdaq:HYPR) to bring magnetic resonance imaging (MRI) to the patient's bedside. San Francisco-based Viz.ai develops the Viz LVO, its flagship product designed to leverage advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat the patient. Hyperfine develops Swoop, which it said is the world's first MR imaging system capable of providing neuroimaging at the point of care, expanding patient access to MRI by bringing imaging to the bedside. Swoop offers a way for physicians to make quick and informed clinical decisions for patients, eliminating hours of wait and transport time, reducing the potential for adverse events associated with transporting critically ill patients. According to a news release, the partnership and subsequent implementation into neuro ICUs provide the potential to further decrease the time from admission to treatment by expanding clinician access to MRI and increasing access to time-critical diagnostics in multiple phases of care.

Stroke is no longer just a danger for seniors as more young adults are suffering them. Lieutenant Governor John Fetterman is 52. Now, Main Line Health has a new technology to help stop strokes faster, if they're recognized quickly. Dominique Jones from Wynnefield just didn't feel right one morning in March. "When I was taking my shower, I had a headache," she recalled.

Baylor St. Luke's Is First in Houston To Adopt Artificial Intelligence for Stroke Care As one of the leaders in stroke care in Houston and the surrounding areas, Baylor St. Luke's Medical Center continues on its promise to leverage the most advanced innovations to provide the best care to its patients. Baylor St. Luke's invested in artificial intelligence technology to service the stroke care team in diagnosing stroke and providing efficient and reliable treatment. Viz.ai technology allows for rapid detection and notification of suspected large vessel occlusion (LVO) strokes. Chethan P Venkatasubba Rao, Medical Director of the Neuroscience ICU at Baylor St. Luke's With Stroke, Timing Is Everything During a stroke, timing is the most important factor for minimizing brain damage. Knowing the signs of a stroke will allow for F.A.S.T. action in the event of an emergency.

The dataset used here is for the stolen bikes in the United Kingdom from 2014 and 2017. It contains the column names such as "Crime ID", "Crime Type", "Falls within"(i.e the police station jurisdiction), "Last outcome category"(i.e the status of the case), and "Location".

In a groundbreaking ruling, CMS has granted Viz.ai the first New Technology Add-on Payment (NTAP) for artificial intelligence software. NTAP, part of the CMS Inpatient Prospective Payment System (IPPS), was set up to support the adoption of cutting-edge technologies that have demonstrated substantial clinical improvement and ensure early availability to Medicare patients. In the US, stroke is the number one cause of long term disability, but is a treatable condition if identified early enough. Viz.ai has been recognized by Forbes, Fast Company, and AuntMinnie as one of the leading AI healthcare companies in the US. The company provides software that improves clinical and financial outcomes1,2 by streamlining acute care, leading to shorter time to treatment, improved patient outcomes, reduced length of stay, and increased number of procedures.

It's no secret that healthcare costs have risen faster than inflation for decades. Some experts estimate that healthcare will account for over 20% of the US GDP by 2025. Meanwhile, doctors are working harder than ever before to treat patients as the U.S. physician shortage continues to grow. Many medical professionals have their schedules packed so tightly that much of the human element which motivated their pursuit of medicine in the first place is reduced. In healthcare, artificial intelligence (AI) can seem intimidating.

It's no secret that healthcare costs have risen faster than inflation for decades. Some experts estimate that healthcare will account for over 20% of the US GDP by 2025. Meanwhile, doctors are working harder than ever before to treat patients as the U.S. physician shortage continues to grow. Many medical professionals have their schedules packed so tightly that much of the human element which motivated their pursuit of medicine in the first place is reduced. In healthcare, artificial intelligence (AI) can seem intimidating.

It's no secret that healthcare costs have risen faster than inflation for decades. Some experts estimate that healthcare will account for over 20% of the US GDP by 2025. Meanwhile, doctors are working harder than ever before to treat patients as the U.S. physician shortage continues to grow. Many medical professionals have their schedules packed so tightly that much of the human element which motivated their pursuit of medicine in the first place is reduced. In healthcare, artificial intelligence (AI) can seem intimidating.